Cargando…
Evaluation of clinical parameters influencing the development of bone metastasis in breast cancer
BACKGROUND: The development of metastases is a negative prognostic parameter for the clinical outcome of breast cancer. Bone constitutes the first site of distant metastases for many affected women. The purpose of this retrospective multicentre study was to evaluate if and how different variables su...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4865990/ https://www.ncbi.nlm.nih.gov/pubmed/27175930 http://dx.doi.org/10.1186/s12885-016-2345-7 |
_version_ | 1782431866702266368 |
---|---|
author | Diessner, Joachim Wischnewsky, Manfred Stüber, Tanja Stein, Roland Krockenberger, Mathias Häusler, Sebastian Janni, Wolfgang Kreienberg, Rolf Blettner, Maria Schwentner, Lukas Wöckel, Achim Bartmann, Catharina |
author_facet | Diessner, Joachim Wischnewsky, Manfred Stüber, Tanja Stein, Roland Krockenberger, Mathias Häusler, Sebastian Janni, Wolfgang Kreienberg, Rolf Blettner, Maria Schwentner, Lukas Wöckel, Achim Bartmann, Catharina |
author_sort | Diessner, Joachim |
collection | PubMed |
description | BACKGROUND: The development of metastases is a negative prognostic parameter for the clinical outcome of breast cancer. Bone constitutes the first site of distant metastases for many affected women. The purpose of this retrospective multicentre study was to evaluate if and how different variables such as primary tumour stage, biological and histological subtype, age at primary diagnosis, tumour size, the number of affected lymph nodes as well as grading influence the development of bone-only metastases. METHODS: This retrospective German multicentre study is based on the BRENDA collective and included 9625 patients with primary breast cancer recruited from 1992 to 2008. In this analysis, we investigated a subgroup of 226 patients with bone-only metastases. Association between bone-only relapse and clinico-pathological risk factors was assessed in multivariate models using the tree-building algorithms “exhausted CHAID (Chi-square Automatic Interaction Detectors)” and CART(Classification and Regression Tree), as well as radial basis function networks (RBF-net), feedforward multilayer perceptron networks (MLP) and logistic regression. RESULTS: Multivariate analysis demonstrated that breast cancer subtypes have the strongest influence on the development of bone-only metastases (χ2 = 28). 29.9 % of patients with luminal A or luminal B (ABC-patients) and 11.4 % with triple negative BC (TNBC) or HER2-overexpressing tumours had bone-only metastases (p < 0.001). Five different mathematical models confirmed this correlation. The second important risk factor is the age at primary diagnosis. Moreover, BC subcategories influence the overall survival from date of metastatic disease of patients with bone-only metastases. Patients with bone-only metastases and TNBC (p < 0.001; HR = 7.47 (95 % CI: 3.52–15.87) or HER2 overexpressing BC (p = 0.007; HR = 3.04 (95 % CI: 1.36–6.80) have the worst outcome compared to patients with luminal A or luminal B tumours and bone-only metastases. CONCLUSION: The bottom line of different mathematical models is the prior importance of subcategories of breast cancer and the age at primary diagnosis for the appearance of osseous metastases. The primary tumour stage, histological subtype, tumour size, the number of affected lymph nodes, grading and NPI seem to have only a minor influence on the development of bone-only metastases. |
format | Online Article Text |
id | pubmed-4865990 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-48659902016-05-14 Evaluation of clinical parameters influencing the development of bone metastasis in breast cancer Diessner, Joachim Wischnewsky, Manfred Stüber, Tanja Stein, Roland Krockenberger, Mathias Häusler, Sebastian Janni, Wolfgang Kreienberg, Rolf Blettner, Maria Schwentner, Lukas Wöckel, Achim Bartmann, Catharina BMC Cancer Research Article BACKGROUND: The development of metastases is a negative prognostic parameter for the clinical outcome of breast cancer. Bone constitutes the first site of distant metastases for many affected women. The purpose of this retrospective multicentre study was to evaluate if and how different variables such as primary tumour stage, biological and histological subtype, age at primary diagnosis, tumour size, the number of affected lymph nodes as well as grading influence the development of bone-only metastases. METHODS: This retrospective German multicentre study is based on the BRENDA collective and included 9625 patients with primary breast cancer recruited from 1992 to 2008. In this analysis, we investigated a subgroup of 226 patients with bone-only metastases. Association between bone-only relapse and clinico-pathological risk factors was assessed in multivariate models using the tree-building algorithms “exhausted CHAID (Chi-square Automatic Interaction Detectors)” and CART(Classification and Regression Tree), as well as radial basis function networks (RBF-net), feedforward multilayer perceptron networks (MLP) and logistic regression. RESULTS: Multivariate analysis demonstrated that breast cancer subtypes have the strongest influence on the development of bone-only metastases (χ2 = 28). 29.9 % of patients with luminal A or luminal B (ABC-patients) and 11.4 % with triple negative BC (TNBC) or HER2-overexpressing tumours had bone-only metastases (p < 0.001). Five different mathematical models confirmed this correlation. The second important risk factor is the age at primary diagnosis. Moreover, BC subcategories influence the overall survival from date of metastatic disease of patients with bone-only metastases. Patients with bone-only metastases and TNBC (p < 0.001; HR = 7.47 (95 % CI: 3.52–15.87) or HER2 overexpressing BC (p = 0.007; HR = 3.04 (95 % CI: 1.36–6.80) have the worst outcome compared to patients with luminal A or luminal B tumours and bone-only metastases. CONCLUSION: The bottom line of different mathematical models is the prior importance of subcategories of breast cancer and the age at primary diagnosis for the appearance of osseous metastases. The primary tumour stage, histological subtype, tumour size, the number of affected lymph nodes, grading and NPI seem to have only a minor influence on the development of bone-only metastases. BioMed Central 2016-05-12 /pmc/articles/PMC4865990/ /pubmed/27175930 http://dx.doi.org/10.1186/s12885-016-2345-7 Text en © Diessner et al. 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Diessner, Joachim Wischnewsky, Manfred Stüber, Tanja Stein, Roland Krockenberger, Mathias Häusler, Sebastian Janni, Wolfgang Kreienberg, Rolf Blettner, Maria Schwentner, Lukas Wöckel, Achim Bartmann, Catharina Evaluation of clinical parameters influencing the development of bone metastasis in breast cancer |
title | Evaluation of clinical parameters influencing the development of bone metastasis in breast cancer |
title_full | Evaluation of clinical parameters influencing the development of bone metastasis in breast cancer |
title_fullStr | Evaluation of clinical parameters influencing the development of bone metastasis in breast cancer |
title_full_unstemmed | Evaluation of clinical parameters influencing the development of bone metastasis in breast cancer |
title_short | Evaluation of clinical parameters influencing the development of bone metastasis in breast cancer |
title_sort | evaluation of clinical parameters influencing the development of bone metastasis in breast cancer |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4865990/ https://www.ncbi.nlm.nih.gov/pubmed/27175930 http://dx.doi.org/10.1186/s12885-016-2345-7 |
work_keys_str_mv | AT diessnerjoachim evaluationofclinicalparametersinfluencingthedevelopmentofbonemetastasisinbreastcancer AT wischnewskymanfred evaluationofclinicalparametersinfluencingthedevelopmentofbonemetastasisinbreastcancer AT stubertanja evaluationofclinicalparametersinfluencingthedevelopmentofbonemetastasisinbreastcancer AT steinroland evaluationofclinicalparametersinfluencingthedevelopmentofbonemetastasisinbreastcancer AT krockenbergermathias evaluationofclinicalparametersinfluencingthedevelopmentofbonemetastasisinbreastcancer AT hauslersebastian evaluationofclinicalparametersinfluencingthedevelopmentofbonemetastasisinbreastcancer AT janniwolfgang evaluationofclinicalparametersinfluencingthedevelopmentofbonemetastasisinbreastcancer AT kreienbergrolf evaluationofclinicalparametersinfluencingthedevelopmentofbonemetastasisinbreastcancer AT blettnermaria evaluationofclinicalparametersinfluencingthedevelopmentofbonemetastasisinbreastcancer AT schwentnerlukas evaluationofclinicalparametersinfluencingthedevelopmentofbonemetastasisinbreastcancer AT wockelachim evaluationofclinicalparametersinfluencingthedevelopmentofbonemetastasisinbreastcancer AT bartmanncatharina evaluationofclinicalparametersinfluencingthedevelopmentofbonemetastasisinbreastcancer |